{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 51.47,
  "market_cap": 228705894400,
  "revenue_ttm": 49770311250.72739,
  "net_income_ttm": 16364909425.517923,
  "ocf_ttm": 19520626254.69352,
  "capex_ttm": 9908865686.09362,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1400210370.6086712,
  "total_debt": 15961357410.832983,
  "cash_and_equivalents": 5138310001.75046,
  "book_value_ttm": 26792447474.369953,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4545546,
  "dividend_yield": 336.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-30T06:29:37Z"
}